Suchergebnisse - "Zhou, Kunli"

PubPharm (7)

1

Decoding real-world outcomes : Exploring clinical features associated with efficacy in patients treated with dupilumab

enthalten in: Journal of the American Academy of Dermatology | 2024

von Tong, Z. | Zhou, K. | Zou, Y. | +8

2

Differential Sampling of AC Waveforms Based on a Commercial Digital-to-Analog Converter for Reference

enthalten in: Sensors (Basel, Switzerland) | 2024

von Wang, Y. | Sun, X. | Zhao, J. | +5

3

Analysis of NF1 gene variants in a Chinese pedigree and a sporadic patient with Neurofibromatosis type 1

enthalten in: Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics | 2024

von Zhao, X. | Zhou, K. | Zhang, Q. | +1

4

Addressing Th1/17-associated immune dysfunction in psoriasis patients enhances the effectiveness of the inactivated SARS-CoV-2 vaccine

enthalten in: Journal of the European Academy of Dermatology and Venereology : JEADV | 2024

von Ji, C. | Zhang, Y. | Li, L. | +15

5

An observational study of abrocitinib in adults with moderate-to-severe atopic dermatitis after switching from dupilumab

enthalten in: Journal of the American Academy of Dermatology | 2023

von Tong, Z. | Zhang, Y. | Zhou, K. | +7

6

An improved electronic determination of the Boltzmann constant by Johnson noise thermometry

enthalten in: Metrologia | 2017

von Qu, J. | Benz, S. | Coakley, K. | +5

7

Endoplasmic reticulum stress-induced autophagy determines the susceptibility of melanoma cells to dabrafenib

enthalten in: Drug design, development and therapy | 2016

von Ji, C. | Zhang, Z. | Chen, L. | +6

RetractionIn: Drug Des Devel Ther. 2023 Jun 22;17:1879-1880. - PMID 37377649

1
[1]